MediciNova, Inc.
METHODS OF TREATING OPHTHALMIC DISEASE/DISORDER OR INJURY WITH IBUDILAST
Last updated:
Abstract:
This disclosure is directed to methods of treating ophthalmic disease/disorder or injury associated with neurodegenerative disease/disorder, such as progressive multiple sclerosis, or a neuro-ophthalmologic disorder in human patients using ibudilast.
Status:
Application
Type:
Utility
Filling date:
18 Oct 2019
Issue date:
23 Apr 2020